National Immunobiological Company (Nacimbio) is a pharmaceutical holding company within the Rostec State Corporation, uniting key Russian manufacturers of immunobiological drugs – NPO Microgen and FORT. Nacimbio’s activities include the development, full- cycle production and supply of vaccines, blood products, bacteriophages, allergens and other medicines. The holding’s product portfolio includes more than 220 drug names.